Mark Leonard Singleton - 04 Apr 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & CFO
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol
BVS
Transactions as of
04 Apr 2022
Net transactions value
$0
Form type
4
Filing time
05 Apr 2022, 21:06:40 UTC
Previous filing
25 Mar 2022
Next filing
23 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +74,500 $0.000000 74,500 04 Apr 2022 Class A Common Stock 74,500 Direct F1, F2
transaction BVS Stock Option (Right to Buy) Award $0 +223,200 $0.000000 223,200 04 Apr 2022 Class A Common Stock 223,200 $13.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 21, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.